|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 233/58 | (2006.01) |
| (11) | Number of the document | 2644591 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13171373.7 |
| Date of filing the European patent application | 2007-08-02 | |
| (97) | Date of publication of the European application | 2013-10-02 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0615620 | 2006-08-05 | GB |
| (72) |
Mitsuda, Masaru, JP
Moroshima, Tadashi, JP
Tsukuya, Kentaro, JP
Watabe, Kazuhiko, JP
Yamada, Masahiko, JP
|
| (73) |
Astrazeneca AB,
151 85 Södertälje,
SE
|
| (54) | OPTICALLY ACTIVE 2-ARYL CYCLOPROPANE CARBOXAMIDE INTERMEDIATE |
| OPTICALLY ACTIVE 2-ARYL CYCLOPROPANE CARBOXAMIDE INTERMEDIATE |